Platelet Aggregation Devices Market Size, Share, Growth Report 2032

Platelet Aggregation Devices Market Size

According to Zion Market Research, the global Platelet Aggregation Devices Market was worth USD 682.15 Million in 2023. The market is forecast to reach USD 1459.68 Million by 2032, growing at a compound annual growth rate (CAGR) of 8.82% during the forecast period 2024-2032. The report offers a comprehensive analysis of the market, highlighting the factors that will determine growth, potential challenges, and opportunities that could emerge in the Platelet Aggregation Devices Market industry over the next decade.

Request Free Sample

Platelet Aggregation Devices Market Overview

The major catalysts for the platelet aggregation devices market comprise rising demand for platelet screening initiatives to verify diseases like Dengue and HIV. Additionally, to the present, the platelet aggregation devices market is likely to power demand from the patient population browsing antiplatelet treatment. Besides this, the rising aged population everywhere on the planet paired with the increasing cases of target diseases also are likely to elevate the event of platelet aggregation devices market in years to return. Moreover, the broad range of platelet aggregation devices’ new applications like recognition of genetically obtained platelet defects and evaluation of surgical bleeding risk also is likely to power the expansion of the platelet aggregation devices market within the near future. On the flip side, the limited scope at the extent of end-users and the high price of purchase are likely to hinder the expansion of the platelet aggregation devices market in years to return.

Despite these limitations, R&D within the platelet aggregation devices market is probably going to be a chance for market growth within the near future. as an example, in September 2017, RMIT and Monash researchers edged nearer to refining a gadget that will rapidly calculate platelet function within the people’s blood that is affected by Willebrand's disease.

COVID-19 Impact Analysis:

The outbreak of COVID-19 worldwide is additionally expected to possess a positive impact on the market, and there's strong evidence that SARS-CoV-2 infection is related to atherothrombotic phenomena. Consistent with the National clinical test Registry (NCT), currently, there are about three clinical trials to work out the effect of COVID-19 on platelet aggregation, which is predicted to drive the platelet aggregation devices market within the coming years. The platelet aggregation devices are meant to treat various cardiovascular diseases and bleeding disorders, but the COVID-19 pandemic is predicted to affect the treatment for these diseases and therefore the supply chain of the devices across the planet.

Request Free Sample

Platelet Aggregation Devices Market: Growth Factors

Aspects such as rising incidences of target diseases, rapid growth in the geriatric population across the globe, technological advancements in platelet aggregometer, and an increasing number of industry-academia collaborations and clinical studies are boosting the growth of the global market. The significant increase in the number of people suffering from cardiovascular diseases ultimately increases the use of platelet aggregation devices to study platelet aggregation worldwide and may drive the market over the forecast period. However, procedural limitations, unfavorable Diagnostic Laboratories reforms in the U.S., and a dearth of well-trained and skilled professionals are some of the key factors restraining the growth of this market.

Platelet Aggregation Devices Market: Segmentation

The Platelet Aggregation Devices market is segmented based on the product, application, end-user and region. Based on product the platelet aggregation devices market is segmented into systems, reagents, consumables & accessories. Based on the application the platelet aggregation device market is segmented into clinical applications and research applications. Based on end-user, it is categorized into; standalone hospitals, research, and academic institutes, diagnostic laboratories, and other end users.

Based on the product, the systems segment is expected to show decent growth over the forecast period. The platelet aggregation system or aggregometer is employed to work out how well the platelets stay together. Such systems measure platelet aggregation with the utilization of a platelet antagonist, like ADP, thrombin, and ristocetin. Aggregation systems are likely to grow over the forecast period due to factors, like continuous technological advances within the field of platelet aggregation devices, the escalation of trends in platelet aggregation testing methods, growing adoption and market preference of automated systems among diagnostic laboratories, and growing advantages offered by point-of-care testing analyzers, as compared to standard instruments.

Request Free Sample

Based on the application segment, clinical applications dominated the market, however, the rising COVID-19 cases and therefore the lockdown and inhibitions on the intercountry transport were found to possess an impression on the availability chain of the systems. Many manufacturers have stopped production due to the shortage of labor that's found to impact the segment growth. Though, the increasing evidence of the effect of COVID-19 on platelet aggregation is resulting in rising research studies on the method.

Based on the End User segment, the need for platelet aggregation systems is growing within the academic and pharmaceutical companies due to the rise in research studies, mostly to understand the mechanisms involved within the interaction of platelets with vascular surfaces and evaluation and screening of anti-thrombotic factors to understand new targets for antiplatelet drugs. Furthermore, the businesses also are taking initiatives to develop their products and expand their presence within the market. 

Platelet Aggregation Devices Market: Report Scope

Platelet Aggregation Devices Market: Regional Analysis

Based on region, in 2023 North America added up for the most important share of the platelet aggregation devices market. it's also likely to develop at the uppermost CAGR within the near future. The U.S. holds the most important share of the platelet aggregation devices market in North America thanks to the attendance of leading players during this area. Moreover, the increasing number of surgical operations, the huge patient population for target diseases, a major number of patients browsing cardiovascular operations, rising awareness amongst Diagnostic Laboratories experts, and rising occurrence of urological, orthopedic, & bleeding disorders also are likely to power the event of platelet aggregation devices market in years to return.

Request Free Sample

Key Market Players & Competitive Landscape

Some of the key players profiled in the report include Major players active in the global platelet aggregation devices market are:

• Helena Laboratories Corporation
• Siemens AG
• Accriva Diagnostics
• Haemonetics Corporation
• Helena Laboratories Corporation
• F. Hoffman-La Roche Ltd
• Aggredyne Inc.
• Sysmex Corporation
• Sentinel Ch. S.P.A.
• TEM Group 
• Among Others

The global Platelet Aggregation Devices market is segmented as follows:   

By Product

• Systems 
• Reagents 
• Consumables & Accessories

By Application

• Clinical Applications 
• Research Applications

By End User

• Standalone Hospitals
• Research and Academic Institutes
• Diagnostic Laboratories
• Other End-Users

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa